Certolizumab Pegol recalls

The FDA has published 1 recall involving Certolizumab Pegol since 2026. The latest was reported on 27 May 2026. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2026

Last 12 months1reported

Class I00% of total

Ongoing1latest 27 May 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 1 0 0Jul 0 0

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why certolizumab pegol is recalled

Sterility1100%

Companies

UCB Biosciences1100%

By year

20261100%

Ongoing certolizumab pegol recalls

1 active

Reported	Class	Recall	Company	Reason	Where
27 May 2026Drug	CLASS II	cimzia (certolizumab pegol), 2x200mg/mL Prefilled Syringes (-dose) recalledCimzia	UCB Biosciences	Sterility	Nationwide

All certolizumab pegol recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
27 May 2026Drug	CLASS II	cimzia (certolizumab pegol), 2x200mg/mL Prefilled Syringes (-dose) recalledCimzia	UCB Biosciences	Sterility	Nationwide

Should you stop taking Certolizumab Pegol?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.